FDA to create and staff inspection offices in China, India

The FDA plans to create and staff inspection offices throughout China and India, and possibly other countries, as a means to step up its regulatory enforcement of the growing inventory of drug products being made abroad, commissioner Andrew von Eschenbach told a House Energy and Commerce subcommittee hearing.
You must be a registered member of MMM to post a comment.

Next Article in Legal/Regulatory


Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.